← Leaderboards
Jason Mathew Butler
Weill Medical Coll Of Cornell Univ
$8,950,258
Attributed
$9,081,806
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,081,806 · 6
By mechanism
R01$8,818,709 · 5
R56$263,097 · 1
Top collaborators
- Christopher Y Park1 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Parag Goyal$4,164,920
- Elliot Omar Eton$54,538
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignCellsSignal TransductionHematopoieticEndotheliumEndothelial CellsBlood VesselsHematopoietic Stem CellsHematopoiesisBone MarrowRecoveryIn VivoPathway InteractionsNatural RegenerationMortalityMorbidity - Disease RateResearch ProposalsVascular SystemAffectHematopoietic SystemMyelosuppressionExperimental StudyCoculture TechniquesSelf-Renewal
Grant awards (20)
Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells$633,009
R01 · FY2025 · HL · contact PI
Netrin-1 promotes the expansion and function of human hematopoietic stem cells by supporting a pro-hematopoietic vascular niche$295,438
R01 · FY2025 · HL · contact PI
Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells$623,117
R01 · FY2024 · HL · contact PI
Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells$651,013
R01 · FY2023 · HL · contact PI
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade$495,677
R01 · FY2023 · AG · contact PI
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade$358,113
R01 · FY2022 · AG · contact PI
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade$217,522
R01 · FY2022 · AG · contact PI
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade$575,635
R01 · FY2021 · AG · contact PI
mTOR Dependent Regulation of Hematopoietic Stem Cell Aging and Longevity$263,097
R56 · FY2021 · AG
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade$575,635
R01 · FY2020 · AG · contact PI
Modulating signaling pathways in endothelial cells to abate leukemic progression$405,116
R01 · FY2020 · CA · contact PI
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade$699,258
R01 · FY2019 · AG · contact PI
Modulating endothelial-specific signaling to enhance functional hematopoesis$442,750
R01 · FY2019 · HL · contact PI
Modulating signaling pathways in endothelial cells to abate leukemic progression$392,962
R01 · FY2019 · CA · contact PI
Modulating endothelial-specific signaling to enhance functional hematopoesis$442,750
R01 · FY2018 · HL · contact PI
Modulating signaling pathways in endothelial cells to abate leukemic progression$405,116
R01 · FY2018 · CA · contact PI
Modulating endothelial-specific signaling to enhance functional hematopoiesis.$419,354
R01 · FY2017 · HL · contact PI
Modulating signaling pathways in endothelial cells to abate leukemic progression.$383,445
R01 · FY2017 · CA · contact PI
Modulating endothelial-specific signaling to enhance functional hematopoiesis.$419,354
R01 · FY2016 · HL · contact PI
Modulating signaling pathways in endothelial cells to abate leukemic progression.$383,445
R01 · FY2016 · CA · contact PI